International Clinical Trial: The 90% effective dose (ED90) of remimazolam for inhibiting responses to the insertion of a gastrointestinal endoscopy in elderly patients with sarcopenia-A Prospective, Double-Blind, Single-Center Clinical Trial

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119967) titled 'The 90% effective dose (ED90) of remimazolam for inhibiting responses to the insertion of a gastrointestinal endoscopy in elderly patients with sarcopenia-A Prospective, Double-Blind, Single-Center Clinical Trial' on March 6.

Study Type: Interventional study

Study Design: Biased Coin Design

Primary Sponsor: The First Affiliated Hospital, Zhejiang University School of Medicine

Condition: None

Intervention: The group of remimazolam:Induction with remimazolam

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-01

Target Sample Size: The group of remimazolam:50;The group of ...